1 / 0
20,800
+$250K
07+$008+$009+$010+$250K
2026-10-13 → 2026-10-13
Open-market Form 4 flow · derivatives and mechanical transactions excluded
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED | DETAILS |
|---|---|---|---|---|---|---|---|---|
| RTSN RETENSION PHARMACEUTICALS, INC. | PURCHASE CHIEF EXECUTIVE OFFICER | 20,800 | $12.00 | $249.6K | 423,377 | Oct 13, 2026 | Oct 13, 2026 ↗ | View → |
| RTSN RETENSION PHARMACEUTICALS, INC. | ACQUIRE CHIEF EXECUTIVE OFFICER | 31,368 | — | — | 464,407 | Oct 13, 2026 | Oct 13, 2026 ↗ | View → |
| RTSN RETENSION PHARMACEUTICALS, INC. | DISPOSE (DERIVATIVE) CHIEF EXECUTIVE OFFICER | 31,368 | — | — | 0 | Oct 13, 2026 | Oct 13, 2026 ↗ | View → |
| RTSN RETENSION PHARMACEUTICALS, INC. | ACQUIRE CHIEF EXECUTIVE OFFICER | 9,662 | — | — | 433,039 | Oct 13, 2026 | Oct 13, 2026 ↗ | View → |
| RTSN RETENSION PHARMACEUTICALS, INC. | DISPOSE (DERIVATIVE) CHIEF EXECUTIVE OFFICER | 9,662 | — | — | 0 | Oct 13, 2026 | Oct 13, 2026 ↗ | View → |
| RTSN RETENSION PHARMACEUTICALS, INC. | ACQUIRE (DERIVATIVE)GRANT Stock grant | 255,174 | — | — | 255,174 | Oct 13, 2026 | Oct 13, 2026 ↗ | View → |